BROSHY ERAN - Insider Non-Derivative Transactions at Theravance Biopharma, Inc. (TBPH) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 26, 2025, BROSHY ERAN's relationship to Theravance Biopharma, Inc. (TBPH) is Director, and currently has 60,204 shares of Ordinary Shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TBPH insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

BROSHY ERAN - Insider Non-Derivative Transactions of TBPH Ordinary Shares

BROSHY ERAN - Insider Non-Derivative Transactions at TBPH

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 27, 2025	Sell -- (Ordinary Shares)	15501	20	44703
Nov 27, 2025	Sell -- (Ordinary Shares)	14000	20	60204
Nov 12, 2025	Sell -- (Ordinary Shares)	15500	17	46204
Nov 12, 2025	Sell -- (Ordinary Shares)	14000	18.5	46204
Nov 12, 2025	Sell -- (Ordinary Shares)	14000	18.5	60204
Nov 12, 2025	Sell -- (Ordinary Shares)	15500	17	60204
Nov 12, 2025	Sell -- (Ordinary Shares)	29500	18.5	61704
Nov 12, 2025	Sell -- (Ordinary Shares)	15500	18.5	75704
May 20, 2025	Acquisition -- (Ordinary Shares)	10649	0	91204
May 9, 2024	Acquisition -- (Ordinary Shares)	10537	0	80555
May 3, 2023	Acquisition -- (Ordinary Shares)	9132	0	70018